Heidi Cuthbert

Proto Labs (NYSE:PRLB) reported record-breaking financial results for the first quarter of 2026, headlined by a more than 120% increase in GAAP net income.

The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of AstraZeneca’s (NYSE:AZN) Truqap (capivasertib) for patients with a particularly aggressive form of prostate cancer.

Solana-based DeFi protocol Carrot is shutting down after suffering severe losses linked to the $285 million Drift Protocol exploit.

Bitcoin exchange-traded funds recorded $137.8 million in net outflows on April 29, led by BlackRock’s IBIT with $54.73 million in exits, marking a third consecutive day of withdrawals.

Binance listed MegaETH’s MEGA token on April 30 without receiving any project allocation or listing fee, marking a rare fee-free launch across major exchanges.

Elon Musk told a California jury that most cryptocurrencies are scams during testimony tied to his legal dispute with OpenAI, marking a shift from his earlier pro-crypto stance.

Xcel Energy (NASDAQ:XEL) reported a resilient start to 2026, posting first-quarter GAAP earnings of $556 million, or $0.89 per share.

Merck (NYSE:MRK) reported a strong opening to 2026, with worldwide sales climbing 5% to $16.3 billion, driven by the continued dominance of its blockbuster cancer therapy and the rapid uptake of its newly launched cardiovascular portfolio.

Carrier Global (NYSE:CARR) reported first-quarter 2026 results that beat Wall Street expectations on the top and bottom lines, despite significant headwinds in the residential HVAC sector.

California Water Service Group (NYSE:CWT) reported first-quarter results that remained largely stable as the utility stands on the verge of a significant regulatory breakthrough.